Top compounds associated with response to PLXND1


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC 0.19 4e-08
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.19 7e-07
mRNA AZ628 GDSC1000 pan-cancer AAC 0.21 1e-05
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA AZD1480 CTRPv2 pan-cancer AAC 0.24 2e-05
mRNA Imatinib GDSC1000 pan-cancer AAC 0.23 2e-05
mRNA AC220 GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA tivozanib CTRPv2 pan-cancer AAC 0.16 3e-05
Download CSV